Skip to main content
. 2021 Jul 28;59:321–326. doi: 10.1016/j.breast.2021.07.017

Table 2.

Treatment-emergent adverse events by preexisting condition.

Adverse Event, % Gastrointestinal
Musculoskeletal
Metabolic
Vascular/Cardiac
PAL + LET
(n = 176)
PBO + LET
(n = 100)
PAL + LET
(n = 252)
PBO + LET
(n = 138)
PAL + LET
(n = 186)
PBO + LET
(n = 73)
PAL + LET
(n = 254)
PBO + LET
(n = 128)
All Grades Grade
3/4
All Grades Grade
3/4
All Grades Grade
3/4
All Grades Grade
3/4
All Grades Grade
3/4
All Grades Grade
3/4
All Grades Grade
3/4
All Grades Grade
3/4
AE in ≥20 % of any group
Neutropenia 83.5 57.4/13.1 8.0 1.0/1.0 80.6 61.1/10.3 8.7 1.4/0.7 79.6 58.6/10.2 2.7 1.4/0 79.9 58.3/10.2 3.1 0.8/0
Infections 65.9 10.8/1.7 47.0 3.0/0 68.3 7.1/0.8 48.6 2.2/0 67.7 8.1/1.6 50.7 5.5/0 63.8 8.7/1.2 46.1 3.9/0
Alopecia 36.9 N/A 19.0 N/A 34.5 N/A 18.1 N/A 34.4 N/A 16.4 N/A 33.9 N/A 16.4 N/A
Arthralgia 36.9 2.3/0 30.0 1.0/0 44.8 1.6/0 36.2 1.4/0 37.1 1.1/0 38.4 1.4/0 36.6 1.2/0 33.6 1.6/0
Leukopenia 44.9 27.3/1.1 4.0 0/0 37.7 23.0/0.8 1.4 0/0 39.2 23.1/0.5 0 0 40.9 25.2/0.8 0.8 0/0
Fatigue 44.3 4.0/0 29.0 1.0/0 50.4 3.2/0 28.3 2.2/0 39.8 2.7/0 31.5 2.7/0 41.7 3.1/0 29.7 2.3/0
Stomatitis 37.5 1.1/0 19.0 0/0 32.5 1.6/0 18.8 0/0 28.0 1.1/0 15.1 0/0 30.7 1.2/0 13.3 0/0
Nausea 40.9 0.6/0 38.0 3.0/0 45.6 0.4/0 30.4 1.4/0 43.0 0/0 34.2 2.7/0 36.6 0/0 25.8 1.6/0
Diarrhea 36.9 2.3/0 26.0 2.0/0 35.3 2.0/0 26.8 1.4/0 34.4 1.6/0 26.0 2.7/0 31.1 2.0/0 20.3 0.8/0
Back pain 31.3 3.4/0 22.0 0/0 30.6 2.8/0 27.5 0/0 23.7 1.1/0 26.0 0/0 24.8 2.0/0 22.7 0/0
Anemia 34.7 6.8/0 10.0 1.0/0 25.8 7.5/0 8.7 0.7/0 30.1 8.6/0 8.2 0/0 29.5 6.7/0.4 5.5 0.8/0
Headache 29.5 0/0 30.0 3.0/0 29.0 0.4/0 31.9 2.9/0 25.8 0/0 34.2 1.4/0 24.4 0.8/0 28.1 1.6/0
Hot flush 28.4 0/0 38.0 0/0 26.6 0/0 36.2 0/0 25.3 0/0 35.6 0/0 22.4 0/0 30.5 0/0
Cough 27.8 0.6/0 20.0 0/0 29.4 0.4/0 22.5 0/0 26.3 0/0 21.9 0/0 28.7 0/0 18.0 0/0
Abdominal pain 19.9 3.4/0 7.0 0/0 16.7 2.0/10 8.0 0/0 14.0 0.5/0 9.6 0/0 15.7 1.2/0 4.7 0/0
Dizziness 19.9 0.6/0 22.0 0/0 19.8 0.8/0 17.4 0/0 17.7 0/0 21.9 0/0 16.9 0.4/0 17.2 0/0
Viral upper RTI 15.3 0/0 10.0 0/0 16.7 0/0 13.0 0/0 22.0 0/0 13.7 0/0 17.7 0/0 10.2 0/0
Asthenia 23.3 5.1/0 10.0 0/0 14.3 2.4/0 11.6 0/0 17.2 1.6/0 13.7 0/0 16.9 3.9/0 11.7 0/0
Rash 23.3 1.1/0 6.0 0/0 22.6 0.8/0 13.0 0.7/0 21.5 1.6/0 13.7 1.4/0 19.7 0.8/0 11.7 0.8/0
Constipation 30.1 1.1/0 19.0 1.0/0 27.4 0.4/0 18.8 0.7/0 24.7 0/0 20.5 1.4/0 22.8 0/0 18.8 0.8/0
Vomiting 25.6 2.3/0 24.0 2.0/0 22.6 0.8/0 19.6 1.4/0 22.6 0.5/0 20.5 2.7/0 17.7 0.4/0 18.0 1.6/0
Decreased appetite 23.3 1.7/0 10.0 0/0 23.4 1.2/0 10.1 0/0 20.4 1.6/0 6.8 0/0 17.7 0.8/0 7.0 0/0
Dyspnea 23.3 1.7/0 18.0 1.0/0 15.5 0.8/0 17.4 1.4/0 18.3 1.6/0 19.2 2.7/0 16.5 0.4/0 16.4 3.1/0
Pain in extremity 23.9 0.6/0 21.0 2.0/0 23.8 0.4/0 22.5 0.7/0 18.8 0/0 17.8 1.4/0 20.1 0.4/0 21.1 1.6/0
AEs of special interest
Febrile neutropenia 2.8 2.3/0.6 0 0/0 2.8 2.4/0.4 0 0/0 2.2 1.6/0.5 0 0 3.1 2.4/0.8 0 0/0
Pulmonary embolism 1.7 0.6/0.6 3.0 1.0/1.0 2.8 2.0/0.4 2.2 0.7/0.7 2.2 2.2/0 2.7 0/1.4 2.0 1.2/0.4 3.1 1.6/0.8
Hypertension 12.5 8.0/0 8.0 7.0/0 9.5 5.6/0 10.1 7.2/0 10.8 7.0/0 11.0 9.6/0 10.2 5.5/0 12.5 10.2/0
Hyperglycemia 5.1 0.6/0 9.0 1.0/0 2.8 0.8/0 6.5 1.4/0 2.7 1.6/0 9.6 2.7/0 5.5 1.2/0 7.8 0.8/0
Hypercholesterolemia 0.6 0/0 3.0 0/0 1.2 0/0 1.4 0/0 1.6 0/0 1.4 0/0 1.6 0/0 2.3 0/0

AE = adverse event; LET = letrozole; N/A = not applicable; PAL = palbociclib; PBO = placebo; RTI = respiratory tract infection.